Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07135362) titled 'The Efficacy Evaluation of TCI604 Probiotic on Intestinal Function Improvement' on Aug. 7.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: TCI Co., Ltd.
Condition:
Constipation
Intestinal Functional Disorder
Intervention:
Dietary Supplement: TCI604 probiotics
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: August 11, 2025
Target Sample Size: 60
Countries of Recruitment:
Taiwan
To know more, visit https://clinicaltrials.gov/ct2/show/NCT0...